229 related articles for article (PubMed ID: 22367268)
21. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes.
Pud D; Ben Ami S; Cooper BA; Aouizerat BE; Cohen D; Radiano R; Naveh P; Nikkhou-Abeles R; Hagbi V; Kachta O; Yaffe A; Miaskowski C
J Pain Symptom Manage; 2008 Feb; 35(2):162-70. PubMed ID: 18082357
[TBL] [Abstract][Full Text] [Related]
22. A symptom cluster and sentinel symptom experienced by women with lung cancer.
Brown JK; Cooley ME; Chernecky C; Sarna L
Oncol Nurs Forum; 2011 Nov; 38(6):E425-35. PubMed ID: 22037342
[TBL] [Abstract][Full Text] [Related]
23. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
Sayao AL; Bueno AM; Devonshire V; Tremlett H;
Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
[TBL] [Abstract][Full Text] [Related]
24. Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma.
Brant JM; Beck SL; Dudley WN; Cobb P; Pepper G; Miaskowski C
Eur J Oncol Nurs; 2011 Dec; 15(5):470-7. PubMed ID: 21251874
[TBL] [Abstract][Full Text] [Related]
25. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
26. Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Weinges-Evers N; Brandt AU; Bock M; Pfueller CF; Dörr J; Bellmann-Strobl J; Scherer P; Urbanek C; Boers C; Ohlraun S; Zipp F; Paul F
Mult Scler; 2010 Sep; 16(9):1134-40. PubMed ID: 20610494
[TBL] [Abstract][Full Text] [Related]
27. Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis.
Braga DM; Prado GF; Bichueti DB; Oliveira EM
Arq Neuropsiquiatr; 2016 Jun; 74(6):433-8. PubMed ID: 27332066
[TBL] [Abstract][Full Text] [Related]
28. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
Hildebrandt H; Eling P
J Clin Exp Neuropsychol; 2014; 36(4):410-7. PubMed ID: 24702275
[TBL] [Abstract][Full Text] [Related]
29. Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation.
Rutledge DN; Mouttapa M; Wood PB
Nurs Res; 2009; 58(5):359-67. PubMed ID: 19752676
[TBL] [Abstract][Full Text] [Related]
30. Symptom cluster as a predictor of physical activity in multiple sclerosis: preliminary evidence.
Motl RW; McAuley E
J Pain Symptom Manage; 2009 Aug; 38(2):270-80. PubMed ID: 19329276
[TBL] [Abstract][Full Text] [Related]
31. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
Zellini F; Niepel G; Tench CR; Constantinescu CS
Mult Scler; 2009 Dec; 15(12):1442-9. PubMed ID: 19995847
[TBL] [Abstract][Full Text] [Related]
32. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
[TBL] [Abstract][Full Text] [Related]
33. Sleep and fatigue in multiple sclerosis.
Stanton BR; Barnes F; Silber E
Mult Scler; 2006 Aug; 12(4):481-6. PubMed ID: 16900762
[TBL] [Abstract][Full Text] [Related]
34. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
Melamud L; Golan D; Luboshitzky R; Lavi I; Miller A
J Neurol Sci; 2012 Mar; 314(1-2):37-40. PubMed ID: 22137446
[TBL] [Abstract][Full Text] [Related]
35. [Fatigue in multiple sclerosis relapsing-remitting form].
Mendes MF; Tilbery HP; Balsimell S; Felipe E; Moreira MA; Barão-Cruz AM
Arq Neuropsiquiatr; 2000 Jun; 58(2B):471-5. PubMed ID: 10920409
[TBL] [Abstract][Full Text] [Related]
36. The relationship of sleep disturbance and symptom severity, symptom interference, and hospitalization among Israeli inpatients with cancer.
Monas L; Csorba S; Kovalyo M; Zeligman R; Dror YF; Musgrave CF
Oncol Nurs Forum; 2012 Jul; 39(4):E361-72. PubMed ID: 22750907
[TBL] [Abstract][Full Text] [Related]
37. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.
Newland PK; Naismith RT; Ullione M
J Neurosci Nurs; 2009 Dec; 41(6):322-8. PubMed ID: 19998683
[TBL] [Abstract][Full Text] [Related]
38. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
39. Cluster analysis of symptom occurrence to identify subgroups of heart failure patients: a pilot study.
Hertzog MA; Pozehl B; Duncan K
J Cardiovasc Nurs; 2010; 25(4):273-83. PubMed ID: 20539162
[TBL] [Abstract][Full Text] [Related]
40. Effects of change in fatigue and depression on physical activity over time in relapsing-remitting multiple sclerosis.
Motl RW; McAuley E; Wynn D; Suh Y; Weikert M
Psychol Health Med; 2011 Jan; 16(1):1-11. PubMed ID: 21218359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
